New Tool to Assess Pyrogenic Risk in Pharmaceutical Processes
: 14 Jun 2019 - 31 Jul 2019
Sector: Other, Pharmaceutical
Webinar recorded: April 9, 2019
Preventing and assessing pyrogenic risk is key for product quality and patient safety. Subcellular components from microorganisms remaining from the production process can be a source of pyrogens as these substances are not eliminated by classical filtration or sterilization steps.
This pyrogenic risk cannot be solely attributed to endotoxins. The Monocyte Activation Test (MAT) is currently the only in vitro method designed for the detection of both endotoxins and non-endotoxin pyrogens (NEPs) that is supported by international regulations.
To learn more about this powerful tool to assess
To learn more about the validation method and results, Click Here